• Logo
  • SBMUJournals

The Effect of ICV Administration of PI3K on Memory

Zahra Yaminifar, Mohammad Nasehi, Mohammad Reza Zarrindast, Kambiz Rohampour




Introduction: Brain insulin receptors (IRs) have been suggested as an important regulatory factor for cognitive functions but the involvement of IR signaling in memory deficit associated with neurodegenerative conditions is not yet explored.  Among the diverse signaling pathways of IR, PI-3 kinase and (MAP) kinase pathways in brain have been suggested for learning and memory functions. The phosphoinositide3-kinase (PI3K) complex plays important roles in virtually all cells of the body. The enzymatic activity of PI3Kto phosphorylate phosphoinositides in the membrane is mediated by a group of catalytic and regulatory subunits. Among those, the class I catalytic subunits, p110α, p110β,p110γ,and p110δ have recently drawn attention in the neuroscience field due to their specific dysregulation in diverse brain disorders. The present study was planned to investigate the effect of PI3K on memory.

Materials and Methods: The animals were injected bilaterally with ICV water (control group), ICV PI3k (1,10 and 100 ng/rat) on days 1 and 3 after surgery.  The learning and memory performance was assessed two weeks after the first dose of drugs by using step-through passive avoidance paradigm (0.3 mA, 3seconds) and open field test. The results revealed that The ICV administration   of PI3K (P<0.05) altered inhibitory avoidance acquisition. PI3K at dose 1 ng/rat decreased the step- through latency during the retention test.

Results: data showed that PI3K at dose of 1 ng/rat decreased the step- through latency during the retention test. In addition, the results showed that PI3K at dose 10 ng/rat increased locomotor activity.

Conclusion: Finally, our data indicated that PI3K has critical role in memory consolidation and locomotor activity.



PI3K, Passive Avoidance, Memory, Rat


Dou J-T, Chen M, Dufour F, Alkon DL, Zhao W-Q. Insulin receptor signaling in long-term memory consolidation following spatial learning. Learning & memory. 2005;12(6):646-55.

Selcher JC, Atkins CM, Trzaskos JM, Paylor R, Sweatt JD. A necessity for MAP kinase activation in mammalian spatial learning. Learning & memory. 1999;6(5):478-90.

Zhao W, Chen H, Xu H, Moore E, Meiri N, Quon MJ, et al. Brain insulin receptors and spatial memory correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. Journal of Biological Chemistry. 1999;274(49):34893-902.

Frölich L, Blum-Degen D, Bernstein H-G, Engelsberger S, Humrich J, Laufer S, et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. Journal of neural transmission. 1998;105(4):423-38.

Takahashi M, Yamada T, Tooyama I, Moroo I, Kimura H, Yamamoto T, et al. Insulin receptor mRNA in the substantia nigra in Parkinson's disease. Neuroscience letters. 1996;204(3):201-4.

Zhao W-Q, Chen H, Quon MJ, Alkon DL. Insulin and the insulin receptor in experimental models of learning and memory. European journal of pharmacology. 2004;490(1):71-81.

Berman DE, Hazvi S, Stehberg J, Bahar A, Dudai Y. Conflicting processes in the extinction of conditioned taste aversion: behavioral and molecular aspects of latency, apparent stagnation, and spontaneous recovery. Learning & Memory. 2003;10(1):16-25.

Berman DE, Dudai Y. Memory extinction, learning anew, and learning the new: dissociations in the molecular machinery of learning in cortex. Science. 2001;291(5512):2417-9.

Lin C-H, Yeh S-H, Leu T-H, Chang W-C, Wang S-T, Gean P-W. Identification of calcineurin as a key signal in the extinction of fear memory. Journal of Neuroscience. 2003;23(5):1574-9.

Lin C-H, Yeh S-H, Lin C-H, Lu K-T, Leu T-H, Chang W-C, et al. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron. 2001;31(5):841-51.

Kritman M, Maroun M. Inhibition of the PI3 kinase cascade in corticolimbic circuit: temporal and differential effects on contextual fear and extinction. International Journal of Neuropsychopharmacology. 2013;16(4):825-33.

Chen X, Garelick MG, Wang H, Li V, Athos J retrieval and extinction of contextual memory. Nature neuroscience. 2005;8(7).

Kelly A, Lynch M. Long-term potentiation in dentate gyrus of the rat is inhibited by the phosphoinositide 3–kinase inhibitor, wortmannin. Neuropharmacology. 2000;39(4):643-51.

Horwood JM, Dufour F, Laroche S, Davis S. Signalling mechanisms mediated by the phosphoinositide 3‐kinase/Akt cascade in synaptic plasticity and memory in the rat. European Journal of Neuroscience. 2006;23(12):3375-84.

Singh M. Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex. Endocrine. 2001;14(3):407-15.

Okkenhaug K. Signaling by the phosphoinositide 3-kinase family in immune cells. Annual review of immunology. 2013;31.

Polak R, Buitenhuis M. The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia. Blood. 2012;119(4):911-23.

Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, et al. The conserved phosphoinositide 3‐kinase pathway determines heart size in mice. The EMBO journal. 2000;19(11):2537-48.

Angulo I, Vadas O, Garçon F, Banham-Hall E, Plagnol V, Leahy TR, et al. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342(6160):866-71.

Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004;304(5670):554-.

Gutierrez A, Sanda T, Grebliunaite R, Carracedo A, Salmena L, Ahn Y, et al. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood. 2009;114(3):647-50.

Jaworski J, Spangler S, Seeburg DP, Hoogenraad CC, Sheng M. Control of dendritic arborization by the phosphoinositide-3′-kinase–Akt–mammalian target of rapamycin pathway. Journal of Neuroscience. 2005;25(49):11300-12.

Chan CB, Liu X, Ensslin MA, Dillehay DL, Ormandy CJ, Sohn P, et al. PIKE‐A is required for prolactin‐mediated STAT5a activation in mammary gland development. The EMBO journal. 2010;29(5):956-68.

Cuesto G, Enriquez-Barreto L, Caramés C, Cantarero M, Gasull X, Sandi C, et al. Phosphoinositide-3-kinase activation controls synaptogenesis and spinogenesis in hippocampal neurons. Journal of Neuroscience. 2011;31(8):2721-33.

Lee C-C, Huang C-C, Hsu K-S. Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways. Neuropharmacology. 2011;61(4):867-79.

Sanna PP, Cammalleri M, Berton F, Simpson C, Lutjens R, Bloom FE, et al. Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region. Journal of Neuroscience. 2002;22(9):3359-65.

Man H-Y, Wang Q, Lu W-Y, Ju W, Ahmadian G, Liu L, et al. Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons. Neuron. 2003;38(4):611-24.

Opazo P, Watabe AM, Grant SG, O'Dell TJ. Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms. Journal of Neuroscience. 2003;23(9):3679-88.

Sui L, Wang J, Li B-M. Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. Learning & Memory. 2008;15(10):762-76.

Hoeffer CA, Klann E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends in neurosciences. 2010;33(2):67-75.

Kalkman HO. The role of the phosphatidylinositide 3-kinase–protein kinase B pathway in schizophrenia. Pharmacology & therapeutics. 2006;110(1):117-34.

Levitt P, Campbell DB. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. The Journal of clinical investigation. 2009;119(4):747.

Karam CS, Ballon JS, Bivens NM, Freyberg Z, Girgis RR, Lizardi-Ortiz JE, et al. Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. Trends in pharmacological sciences. 2010;31(8):381-90.

Waite K, Eickholt BJ. The neurodevelopmental implications of PI3K signaling. Phosphoinositide 3-kinase in Health and Disease: Springer; 2010. p. 245-65.

Krueger DA, Wilfong AA, Holland‐Bouley K, Anderson AE, Agricola K, Tudor C, et al. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Annals of neurology. 2013;74(5):679-87.

Hawkins P, Anderson K, Davidson K, Stephens L. Signalling through Class I PI3Ks in mammalian cells. Biochemical Society Transactions. 2006;34(5):647-62.

Gross C, Bassell GJ. Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders. Frontiers in molecular neuroscience. 2014;7.

Brown RE, Corey SC, Moore AK. Differences in measures of exploration and fear in MHC-congenic C57BL/6J and B6-H-2K mice. Behavior genetics. 1999;29(4):263-71.

CARREY N, McFADYEN MP, BROWN RE. Effects of subchronic methylphenidate hydrochloride administration on the locomotor and exploratory behavior of prepubertal mice. Journal of child and adolescent psychopharmacology. 2000;10(4):277-86.

Gutierres JM, Carvalho FB, Rosa MM, Schmatz R, Rodrigues M, Vieira JM, et al. Protective effect of α-Tocopherol on memory deficits and Na+, K+-ATPase and acetylcholinesterase activities in rats with diet-induced hypercholesterolemia. Biomedicine & Aging Pathology. 2012;2(3):73-80.

Eisenberg M, Kobilo T, Berman DE, Dudai Y. Stability of retrieved memory: inverse correlation with trace dominance. Science. 2003;301(5636):1102-4.

Aksamitiene E, Kiyatkin A, Kholodenko BN. Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance. Portland Press Limited; 2012.

Wang P, Xu TY, Guan YF, Tian WW, Viollet B, Rui YC, et al. Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1‐dependent adenosine monophosphate–activated kinase pathway. Annals of neurology. 2011;69(2):360-74.

Agrawal R, Tyagi E, Shukla R, Nath C. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology. 2009;56(4):779-87.

Slouzkey I, Rosenblum K, Maroun M. Memory of conditioned taste aversion is erased by inhibition of PI3K in the insular cortex. Neuropsychopharmacology. 2013;38(7):1143-53.

Koh MT, Thiele TE, Bernstein IL. Inhibition of protein kinase A activity interferes with long-term, but not short-term, memory of conditioned taste aversions. Behavioral neuroscience. 2002;116(6):1070.

Miranda MI, McGaugh JL. Enhancement of inhibitory avoidance and conditioned taste aversion memory with insular cortex infusions of 8-Br-cAMP: involvement of the basolateral amygdala. Learning & Memory. 2004;11(3):312-7.

Frankland PW, Ding H-K, Takahashi E, Suzuki A, Kida S, Silva AJ. Stability of recent and remote contextual fear memory. Learning & memory. 2006;13(4):451-7.

Mamiya N, Fukushima H, Suzuki A, Matsuyama Z, Homma S, Frankland PW, et al. Brain region-specific gene expression activation required for reconsolidation and extinction of contextual fear memory. Journal of Neuroscience. 2009;29(2):402-13.

Rosenblum K, Schul R, Meiri N, Hadari YR, Zick Y, Dudai Y. Modulation of protein tyrosine phosphorylation in rat insular cortex after conditioned taste aversion training. Proceedings of the National Academy of Sciences. 1995;92(4):1157-11561

DOI: https://doi.org/10.22037/aab.v10i3.19471


  • There are currently no refbacks.